Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Gynecologic 1Genitourinary 1Gastrointestinal 1

Conditions

Gliosarcoma 31Glioblastoma 30Sarcoma 22Rhabdomyosarcoma 8Brain Neoplasms 7Astrocytoma 7Central Nervous System Neoplasms 6Melanoma 4Liposarcoma 4Histiocytoma, Malignant Fibrous 4Glioma 4Bone Neoplasms 4Sarcoma, Synovial 3Sarcoma, Ewing 3Rhabdomyosarcoma, Embryonal 3Osteosarcoma 3Neoplasm Metastasis 3Leiomyosarcoma 3Breast Neoplasms 3Rhabdomyosarcoma, Alveolar 2Prostatic Neoplasms 2Pain 2Ovarian Neoplasms 2Oligodendroglioma 2Neurofibrosarcoma 2Neoplasms 2Medulloblastoma 2Dermatofibrosarcoma 2Carcinoma, Merkel Cell 2Vulvar Neoplasms 1

Interventions

Radiation 1Octreotide 1Diet Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Diarrhea × Radiation × Sarcoma × Clear all
NCT00033605 2016-07-13

Octreotide in Preventing Diarrhea in Patients Who Are Undergoing Radiation Therapy to the Pelvis

Alliance for Clinical Trials in Oncology

Phase 3 Completed
130 enrolled
GastrointestinalGenitourinaryGynecologicSarcoma

Uterine Cervical Neoplasms, Diarrhea, Fallopian Tube Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Sarcoma, Vaginal Neoplasms, Vulvar Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡